17 May 2021 : Clinical Research
Immunogenicity of Split Inactivated Quadrivalent Influenza Vaccine in Adults with Obesity in the 2017/2018 Season
Anna M. Jagielska


DOI: 10.12659/MSM.929572
Med Sci Monit 2021; 27:e929572
Table 2 Pre-vaccination and post-vaccination anti-HI titers against influenza virus strains (N=53).
Antibodies | Pre-vaccination | Post-vaccination | P value* | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
M | ±SD | Me | Min | Max | M | ±SD | Me | Min | Max | ||
A/Michigan/45/2015 (A/H1N1/pdm09)-like strain | 11.5 | 34.2 | 0 | 0 | 160 | 184.2 | 211.1 | 80 | 0 | 640 | <0.01 |
A/Hong Kong/4801/2014 (A/H3N2/)-like strain | 5.7 | 24.4 | 0 | 0 | 160 | 175.5 | 201.1 | 80 | 0 | 640 | <0.01 |
B/Brisbane/60/2008-like strain (Victoria lineage) | 24.3 | 27.7 | 20 | 0 | 160 | 230.6 | 196.2 | 160 | 0 | 640 | <0.01 |
B/Phuket/3073/2013-like strain (Yamagata lineage) | 49.8 | 26.5 | 40 | 0 | 80 | 181.5 | 153.8 | 160 | 0 | 640 | <0.01 |
M – mean; SD – standard deviation; Me – median; Min – minimum; Max – maximum; * (pre- versus post-vaccination). |